The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Narcolepsy is a neurological disorder that affects the control of sleep and wakefulness. People with narcolepsy experience excessive daytime sleepiness and intermittent, uncontrollable episodes of falling asleep during the daytime. These sudden sleep attacks may occur during any type of activity at any time of the day.
The global Narcolepsy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Narcolepsy in various end use industries.
The expanding demands from the Hospitals, Clinics and Others,, are propelling Narcolepsy market. Daytime Extreme Sleepiness, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cataplexia segment is estimated at % CAGR for the next seven-year period.
People with narcolepsy can be substantially helped, but not cured. Treatment is tailored to the individual, based on symptoms and therapeutic response. The time required to achieve optimal control of symptoms is highly variable and may take several months or longer. Medication adjustments are frequently necessary, and complete control of symptoms is seldom possible. While oral medications are the mainstay of formal narcolepsy treatment, lifestyle changes are also important.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Narcolepsy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Narcolepsy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Narcolepsy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Narcolepsy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Narcolepsy covered in this report include Jazz Pharmaceuticals, Bioprojet, Arena Pharmaceuticals, Graymark Healthcare, Mylan, Teva Pharmaceutical Industries, Novartis, Takeda and Shionogi, etc.
The global Narcolepsy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
- Jazz Pharmaceuticals
- Bioprojet
- Arena Pharmaceuticals
- Graymark Healthcare
- Mylan
- Teva Pharmaceutical Industries
- Novartis
- Takeda
- Shionogi
- Ligand Pharmaceuticals
Global Narcolepsy market, by region:
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, etc.)
- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
- South America (Brazil, etc.)
- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Narcolepsy market, Segment by Type:
- Daytime Extreme Sleepiness
- Cataplexia
- Others
Global Narcolepsy market, by Application
- Hospitals
- Clinics
- Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Narcolepsy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Narcolepsy
1.1 Narcolepsy Market Overview
1.1.1 Narcolepsy Product Scope
1.1.2 Narcolepsy Market Status and Outlook
1.2 Global Narcolepsy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Narcolepsy Market Size by Region (2018-2029)
1.4 Global Narcolepsy Historic Market Size by Region (2018-2023)
1.5 Global Narcolepsy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Narcolepsy Market Size (2018-2029)
1.6.1 North America Narcolepsy Market Size (2018-2029)
1.6.2 Europe Narcolepsy Market Size (2018-2029)
1.6.3 Asia-Pacific Narcolepsy Market Size (2018-2029)
1.6.4 Latin America Narcolepsy Market Size (2018-2029)
1.6.5 Middle East & Africa Narcolepsy Market Size (2018-2029)
2 Narcolepsy Market by Type
2.1 Introduction
2.1.1 Daytime Extreme Sleepiness
2.1.2 Cataplexia
2.1.3 Others
2.2 Global Narcolepsy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Narcolepsy Historic Market Size by Type (2018-2023)
2.2.2 Global Narcolepsy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Narcolepsy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Narcolepsy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Narcolepsy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Narcolepsy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Narcolepsy Revenue Breakdown by Type (2018-2029)
3 Narcolepsy Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Narcolepsy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Narcolepsy Historic Market Size by Application (2018-2023)
3.2.2 Global Narcolepsy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Narcolepsy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Narcolepsy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Narcolepsy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Narcolepsy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Narcolepsy Revenue Breakdown by Application (2018-2029)
4 Narcolepsy Competition Analysis by Players
4.1 Global Narcolepsy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Narcolepsy as of 2022)
4.3 Date of Key Players Enter into Narcolepsy Market
4.4 Global Top Players Narcolepsy Headquarters and Area Served
4.5 Key Players Narcolepsy Product Solution and Service
4.6 Competitive Status
4.6.1 Narcolepsy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Jazz Pharmaceuticals
5.1.1 Jazz Pharmaceuticals Profile
5.1.2 Jazz Pharmaceuticals Main Business
5.1.3 Jazz Pharmaceuticals Narcolepsy Products, Services and Solutions
5.1.4 Jazz Pharmaceuticals Narcolepsy Revenue (US$ Million) & (2018-2023)
5.1.5 Jazz Pharmaceuticals Recent Developments
5.2 Bioprojet
5.2.1 Bioprojet Profile
5.2.2 Bioprojet Main Business
5.2.3 Bioprojet Narcolepsy Products, Services and Solutions
5.2.4 Bioprojet Narcolepsy Revenue (US$ Million) & (2018-2023)
5.2.5 Bioprojet Recent Developments
5.3 Arena Pharmaceuticals
5.3.1 Arena Pharmaceuticals Profile
5.3.2 Arena Pharmaceuticals Main Business
5.3.3 Arena Pharmaceuticals Narcolepsy Products, Services and Solutions
5.3.4 Arena Pharmaceuticals Narcolepsy Revenue (US$ Million) & (2018-2023)
5.3.5 Graymark Healthcare Recent Developments
5.4 Graymark Healthcare
5.4.1 Graymark Healthcare Profile
5.4.2 Graymark Healthcare Main Business
5.4.3 Graymark Healthcare Narcolepsy Products, Services and Solutions
5.4.4 Graymark Healthcare Narcolepsy Revenue (US$ Million) & (2018-2023)
5.4.5 Graymark Healthcare Recent Developments
5.5 Mylan
5.5.1 Mylan Profile
5.5.2 Mylan Main Business
5.5.3 Mylan Narcolepsy Products, Services and Solutions
5.5.4 Mylan Narcolepsy Revenue (US$ Million) & (2018-2023)
5.5.5 Mylan Recent Developments
5.6 Teva Pharmaceutical Industries
5.6.1 Teva Pharmaceutical Industries Profile
5.6.2 Teva Pharmaceutical Industries Main Business
5.6.3 Teva Pharmaceutical Industries Narcolepsy Products, Services and Solutions
5.6.4 Teva Pharmaceutical Industries Narcolepsy Revenue (US$ Million) & (2018-2023)
5.6.5 Teva Pharmaceutical Industries Recent Developments
5.7 Novartis
5.7.1 Novartis Profile
5.7.2 Novartis Main Business
5.7.3 Novartis Narcolepsy Products, Services and Solutions
5.7.4 Novartis Narcolepsy Revenue (US$ Million) & (2018-2023)
5.7.5 Novartis Recent Developments
5.8 Takeda
5.8.1 Takeda Profile
5.8.2 Takeda Main Business
5.8.3 Takeda Narcolepsy Products, Services and Solutions
5.8.4 Takeda Narcolepsy Revenue (US$ Million) & (2018-2023)
5.8.5 Takeda Recent Developments
5.9 Shionogi
5.9.1 Shionogi Profile
5.9.2 Shionogi Main Business
5.9.3 Shionogi Narcolepsy Products, Services and Solutions
5.9.4 Shionogi Narcolepsy Revenue (US$ Million) & (2018-2023)
5.9.5 Shionogi Recent Developments
5.10 Ligand Pharmaceuticals
5.10.1 Ligand Pharmaceuticals Profile
5.10.2 Ligand Pharmaceuticals Main Business
5.10.3 Ligand Pharmaceuticals Narcolepsy Products, Services and Solutions
5.10.4 Ligand Pharmaceuticals Narcolepsy Revenue (US$ Million) & (2018-2023)
5.10.5 Ligand Pharmaceuticals Recent Developments
6 North America
6.1 North America Narcolepsy Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Narcolepsy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Narcolepsy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Narcolepsy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Narcolepsy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Narcolepsy Market Dynamics
11.1 Narcolepsy Industry Trends
11.2 Narcolepsy Market Drivers
11.3 Narcolepsy Market Challenges
11.4 Narcolepsy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
